The above findings suggest that the TREM2+ macrophage subgroup may play an important role in tumor development and metastasis and could serve as a new target for combined immunotherapy to enhance the efficacy of anti-PD-L1 treatment. This evidence concerns the gene CD274 and neoplasm.